Biblioteca Virtual em Saúde

Pesquisa | Influenza A (H1N1)

  • BIREME | OPAS | OMS logo
português español english
 
Entre uma ou mais palavras onde:
Influenza A (H1N1) > Pesquisa
Exportar em RSS XML
Imprimir
Ordenar por

Histórico de pesquisa  ()

Sua seleção  ()

 0 documento(s) selecionado(s).

Refine sua pesquisa

Collapse All  Ocultar
Expand All  Mostrar
Áreas temáticas
Texto completo (2423)
Idioma
Ano de publicação

Enviar por email

Você tem 0 documento(s) selecionado(s).

Nenhum documento selecionado

 
Resultados  1-12 de 12.140
1.

Transmission and control of an emerging influenza pandemic in a small-world airline network.

Autor(es): Hsu CI; Shih HH
Fonte: Accid Anal Prev;42(1): 93-100, 2010 Jan.
PMID: 19887149
Resumo: The avian influenza virus H5N1 and the 2009 swine flu H1N1 are potentially serious pandemic threats to human health, and air travel readily facilitates the spread of infectious diseases. However, past studies have not yet incorporated the effects of air travel on the transmission of influenza in the construction of mathematical epidemic models. Therefore, this paper focused on the human-to-human transmission of influenza, and investigated the effects of air travel activities on an influenza (mais)
2.

Facts you should know about the H1N1 influenza pandemic.

Autor(es): Merchant VA
Fonte: J Mich Dent Assoc;91(10): 38-9, 2009 Oct.
PMID: 19877489
3.

"Dunkirk spirit:" differences between United Kingdom and United States responses to pandemic influenza.

Autor(es): Sorell T; Draper H; Damery S; Ives J
Fonte: Am J Bioeth;9(11): 21-2, 2009 Nov.
PMID: 19882448
4.

The novel influenza A (H1N1) virus pandemic: An update.

Autor(es): Petrosillo N; Di Bella S; Drapeau CM; Grilli E
Fonte: Ann Thorac Med;4(4): 163-72, 2009 Oct.
PMID: 19881161
Resumo: In the 4 months since it was first recognized, the pandemic strain of a novel influenza A (H1N1) virus has spread to all continents and, after documentation of human-to-human transmission of the virus in at least three countries in two separate World Health Organization (WHO) regions, the pandemic alert was raised to level 6. The agent responsible for this pandemic, a swine-origin influenza A (H1N1) virus (S-OIV), is characterized by a unique combination of gene segments that has not previo (mais)
5.

Influenza A(H1N1) and infection control guidelines for optometrists.

Autor(es): Kiely PM; Lian KY; Napper G; Lakkis C
Fonte: Clin Exp Optom;92(6): 490-4, 2009 Nov.
PMID: 19758421
Resumo: The emergence of a novel influenza A virus (Influenza A[H1N1]), which has not circulated previously in humans, has led to the first global influenza pandemic in 41 years. Influenza A(H1N1), commonly called 'swine flu', is a novel influenza virus made up of porcine, avian and human genes, and preferentially infects younger people. Although Influenza A(H1N1) does not appear to be likely to cause as many fatalities as previous influenza pandemics, attempts to contain it are necessary because p (mais)
6.

Heart failure in swine flu: a note.

Autor(es): Wiwanitkit V
Fonte: J Card Fail;15(9): 812, 2009 Nov.
PMID: 19879469
8.

Management of H1N1 influenza virus respiratory syndrome.

Autor(es): De Rosa FG; Montrucchio C; Di Perri G
Fonte: Minerva Anestesiol;75(11): 654-60, 2009 Nov.
PMID: 19881461
Resumo: In 2009 a new H1N1 Influenza A has been identified in Mexico, with secondary spread worldwide. The main clinical features are represented by a mild respiratory tract infection, but there are reports of complicated cases with fatalities even in patients without comorbidities. This review summarizes the current concepts of epidemiology, diagnosis, treatment and infection control issues of the disease caused by the new H1N1 Influenza A virus.
9.

Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.

Autor(es): Price GE; Soboleski MR; Lo CY; Misplon JA; Pappas C; Houser KV; Tumpey TM; Epstein SL
Fonte: Vaccine;27(47): 6512-21, 2009 Nov 5.
PMID: 19729082
Resumo: Immunization against conserved virus components induces broad, heterosubtypic protection against diverse influenza A viruses, providing a strategy for controlling unexpected outbreaks or pandemics until strain-matched vaccines become available. This study characterized immunization to nucleoprotein (NP) and matrix 2 (M2) by DNA priming followed by parenteral or mucosal boosting in mice and ferrets. DNA vaccination followed by boosting with antigen-matched recombinant adenovirus (rAd) or col (mais)
10.

Emerging swine flu and increased report of AEFI to classical influenza vaccination.

Autor(es): Wiwanitkit V
Fonte: Vaccine;27(48): 6651, 2009 Nov 12.
PMID: 19717134
11.

Influenza A (H1N1) 2009 monovalent vaccine: laboratory confirmation of vaccine breakdowns.

Autor(es): Arya SC; Nirmala A
Fonte: Vaccine;27(49): 6808, 2009 Nov 16.
PMID: 19765396
12.

Parental attitude toward influenza A(H1N1)v vaccination in Italy.

Autor(es): Tozzi AE; Gesualdo F; Romano M; Caione D
Fonte: Vaccine;27(49): 6807, 2009 Nov 16.
PMID: 19781680
Resultados  1-12 de 12.140
powered by iAHx-1.2-rev.167 Biblioteca Virtual em Saúde
página inicial | sobre a BVS